| abstract |
A pharmaceutical composition adapted for pulmonary administration by inhalation comprising a glitazone, such as pioglitazone or rosiglitazone, and one or more pharmaceutically acceptable carriers and / or excipients, the glitazone content being at least 95 Provided is a pharmaceutical composition as described above, consisting of 5% by weight of 5R enantiomer and less than 5% by weight of 5S enantiomer. Uses and kits are also provided. [Selection] Figure 1 |